Ren et al. demonstrated that in colon cancer, TTC7B triggers the RXRA-FTO axis by binding to PI4KA, reducing m6A modification of total RNA and inhibiting colon cancer cell proliferation 20. Here, RXRA is linked to malignant colon neoplasm.